Dr Gregor TEVZ
Position:
- Postdoctoral Fellow, Australian Prostate Cancer Research Centre-Q, Queensland University of Technology and Translational Research Institute, Institute of Health and Biomedical Innovation
Credentials:
- PhD at Institute of Oncology Ljubljana, Slovenia
Biography:
Dr Gregor Tevz is a Research Fellow at the Australian Prostate Cancer Research Centre-Queensland where he is investigating the role of the relaxin peptide and receptor family in adaptive response of prostate cancer to androgen targeted therapies. Through his education and work experience, he gained skills in translational research and knowledge of prostate cancer biology. In his PhD, he showed improved safety and efficiency of IL-12 gene therapy in combination with radiotherapy, within a translational oriented programme lead by Dr. Sersa, which developed electrochemotherapy as a standard treatment for palliative care of patients with subcutaneous metastases. Following his PhD, Dr Tevz joined the Marie Curie initial training consortium of major European prostate cancer research institutions. Within the consortium he took a postdoctoral position in industry at Philips Research, where he worked in a prostate cancer biomarker discovery project PrognostiX that was awarded first prize at the 2011 NGI Venture Challenge.
Best publications:
1: An J, Lai J, Wood DL, Sajjanhar A, Wang C, Tevz G, Lehman ML, Nelson CC.
RNASeqBrowser: a genome browser for simultaneous visualization of raw strand
specific RNAseq reads and UCSC genome browser custom tracks. BMC Genomics. 2015
Mar 1;16:145. doi: 10.1186/s12864-015-1346-2. PubMed PMID: 25766521; PubMed
Central PMCID: PMC4355470.
2: Jeet V, Tevz G, Lehman M, Hollier B, Nelson C. Elevated YKL40 is associated
with advanced prostate cancer (PCa) and positively regulates invasion and
migration of PCa cells. Endocr Relat Cancer. 2014 Oct;21(5):723-37. doi:
10.1530/ERC-14-0267. Epub 2014 Jun 30. PubMed PMID: 24981110; PubMed Central
PMCID: PMC4134518.
3: Tevz G, Bencina M, Legisa M. Enhancing itaconic acid production by Aspergillus
terreus. Appl Microbiol Biotechnol. 2010 Aug;87(5):1657-64. doi:
10.1007/s00253-010-2642-z. Epub 2010 May 12. PubMed PMID: 20461508.
4: Tevz G, Kranjc S, Cemazar M, Kamensek U, Coer A, Krzan M, Vidic S, Pavlin D,
Sersa G. Controlled systemic release of interleukin-12 after gene electrotransfer
to muscle for cancer gene therapy alone or in combination with ionizing radiation
in murine sarcomas. J Gene Med. 2009 Dec;11(12):1125-37. doi: 10.1002/jgm.1403.
PubMed PMID: 19777440.
5: Tevz G, Pavlin D, Kamensek U, Kranjc S, Mesojednik S, Coer A, Sersa G, Cemazar
M. Gene electrotransfer into murine skeletal muscle: a systematic analysis of
parameters for long-term gene expression. Technol Cancer Res Treat. 2008
Apr;7(2):91-101. PubMed PMID: 18345697.
Work Focus:
- Work Focus (Biomedical): Relaxin signaling in prostate cancer
prostate cancer, translational cancer research, drug discovery, in vivo cancer therapy.
qPCR, live microscopy imaging,.
